Resumen
Pseudomonas aeruginosa, a Gram-negative bacterium, is a member of the ESKAPE pathogens and one of the leading causes of healthcare-associated infections worldwide. Aminoglycosides (AGs) are recognized for their efficacy against P. aeruginosa. The most common resistance mechanism against AGs is the acquisition of AG-modifying enzymes (AMEs) by the bacteria, including AG N-acetyltransferases (AACs), AG O-phosphotransferases (APHs), and AG O-nucleotidyltransferases (ANTs). In this study, we obtained 122 multidrug-resistant P. aeruginosa clinical isolates and evaluated the antibacterial effects of six AGs and two carbapenems alone against all clinical isolates, and in combination against eight selected strains. We further probed for four representatives of the most common AME genes [aac(6′)-Ib, aac(3)-IV, ant(2»)-Ia, and aph(3′)-Ia] by polymerase chain reaction (PCR) and compared the AME patterns of these 122 clinical isolates to their antibiotic resistance profile. Among the diverse antibiotics resistance profile displayed by these clinical isolates, we found correlations between the resistance to various AGs as well as between the resistance to one AG and the resistance to carbapenems. PCR results revealed that the presence of aac(6′)-Ib renders these isolates more resistant to a variety of antibiotics. The correlation between resistance to various AGs and carbapenems partially reflects the complex resistance strategies adapted in these pathogens and encourages the development of strategic treatment for each P. aeruginosa infection by considering the genetic information of each isolated bacteria.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 1020-1030 |
| Número de páginas | 11 |
| Publicación | Microbial Drug Resistance |
| Volumen | 24 |
| N.º | 7 |
| DOI | |
| Estado | Published - sept 2018 |
Nota bibliográfica
Publisher Copyright:© 2018 Mary Ann Liebert, Inc.
Financiación
This work was supported by NIH grant AI090048 (to S.G.-T.). S.Y.L.H. was in part supported by a University of Kentucky Presidential Fellowship. We thank Prof. David S. Burgess for sharing with us the clinical isolates that we used in this study.
| Financiadores | Número del financiador |
|---|---|
| National Institutes of Health (NIH) | |
| National Institute of Allergy and Infectious Diseases | R01AI090048 |
| National Institute of Allergy and Infectious Diseases | |
| University of Kentucky |
ASJC Scopus subject areas
- Microbiology
- Immunology
- Pharmacology
- Microbiology (medical)
Huella
Profundice en los temas de investigación de 'Evaluation of aminoglycoside and carbapenem resistance in a collection of drug-resistant pseudomonas aeruginosa clinical isolates'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver